Remimazolam Versus Midaszolam for Sedation in Diagnostic Upper Gastrointestinal Endoscopy
Status:
Not yet recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to compare the efficacy of remimazolam with midazolam in
patients undergoing gastrointestinal endoscopy. The main questions it aims to answer are:
- Superiority of total procedure time in remimazolam compared to midazolam
- The success of sedation time
This is the single blind study.; Patients will not know what they are given as the sedation
drug If there is a comparison group: Researchers will compare patients with midazolam group
to see if remimazolam group is superior to midazolam group